Is the problem of the international standard for low molecular weight heparin crucial for the clinician?
Toulemonde
F
F
Institut Choay-Sanofi, Gentilly, France.
D002986:Clinical Trials as Topic; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000592:standards*; D006801:Humans; D011655:Pulmonary Embolism / Q000188:drug therapy; D013924:Thrombophlebitis / Q000188:drug therapy
D006495:Heparin, Low-Molecular-Weight